The Dirty Truth About Scented Candles YouTuber and physician Dr. Mike discusses possible dangers of burning candles Jun 27, 2024
FDA Approves Novel Nebulized Therapy for COPD First-in-class dual phosphodiesterase inhibitor lands broad indication for COPD maintenance Jun 27, 2024
GLP-1 Agonists in Adolescents and Young Adults; Benefits of Cancer Drug Trials Also in TTHealthWatch: early diagnosis and treatment of COPD and asthma May 25, 2024 podcast
Tezepelumab Shows Potential for COPD, Negative Trial Notwithstanding Asthma drug may benefit patients with blood eosinophil counts indicative of type 2 inflammation May 22, 2024
Add-On Dupilumab for COPD Backed by Second Phase III Trial NOTUS study confirms fewer exacerbations with biologic for patients on maximum inhaled therapy May 21, 2024
Beta-Blocker Fails to Prevent COPD Exacerbations However, trial results don't affirm safety risks suggested by other studies May 20, 2024
Finding Undiagnosed Asthma, COPD and Treating It Shows Benefit in Trial Healthcare utilization for respiratory illness halved while quality of life, symptoms improved May 20, 2024
Can You Guess Which New EPA Rule Offers $13 Billion in Annual Health Benefits? The new clean car standards provide health and climate benefits alike Apr 07, 2024
Female Reproductive Factors Linked to COPD Risk Age at menarche and menopause, number of children seem to play a role Feb 13, 2024
Telehealth, Default Orders Show Promise in Palliative Care Telecare improved quality of life for people with chronic illnesses Jan 17, 2024
Gabapentinoids in COPD Patients May Raise Risk for Severe Exacerbations 39% higher risk compared with nonusers, database study finds Jan 16, 2024
Dupilumab in Line to Be the First Approved COPD Biologic In two phase III trials, the treatment reduced exacerbations and improved lung function Dec 28, 2023
FDA Rejects Drug for Chronic Cough Agency cites efficacy concerns in review of P2X3 receptor antagonist gefapixant Dec 21, 2023
Drug Candidate for Chronic Cough Rejected by FDA Panel Gefapixant's benefit not clinically meaningful enough, panelists say Nov 17, 2023
Unclear if Chronic Cough Drug Has Meaningful Benefit, FDA Reviewers Say Previously rejected gefapixant will face agency's panel of outside experts on Friday Nov 16, 2023
Using AI to Predict Exacerbations in Uncontrolled COPD This is the "wave of the future," says Reynold Panettieri Nov 01, 2023 video
Cold Temps Tied to More COPD Hospitalizations in Older Adults Temperatures below 65°F, and particularly those under 20°F, increased risk Oct 13, 2023
Concept of 'Asthma-COPD Overlap' Still Alive Despite Detractors Is it a moot point under the treatable traits paradigm? Oct 10, 2023
Mortality Risk From Damaged Bronchi Extends to People Without COPD Findings support use of lung imaging for clinically defining bronchiectasis, study authors say Oct 02, 2023
ERS Roundup: Cell Transplant Boosts Lung Function in COPD Patients Plus: idrevloride for primary ciliary dyskinesia and ultrasound for pulmonary embolism Sep 15, 2023
Acetazolamide May Help COPD Patients Reach New Heights Along with self-monitoring, treatment limited altitude-related adverse health effects vs placebo Sep 13, 2023
Early Oophorectomy May Accelerate Onset of Chronic Health Problems Premenopausal bilateral oophorectomy tied to higher odds of arthritis, sleep apnea, and more Sep 13, 2023
Climate Change a 'Major Threat' for Respiratory Patients, Experts Warn ERS statement suggests action for individual physicians with affected patients Sep 06, 2023
COPD Inhalers' Link to Fracture Risk Supported in Pooled Trials Certain treatment regimens associated with increased risk of fracture Aug 21, 2023
Generic Fluticasone–Salmeterol Inhaler for COPD Matches Branded Product Similar incidences of exacerbation, pneumonia hospitalization between inhalers Aug 07, 2023
Dual Phosphodiesterase Inhibitor Improved Lung Function in COPD Patients Ensifentrine also reduced moderate-to-severe exacerbations May 24, 2023
Real-World Data on COPD Combo Inhalers Favor LAMA-LABAs Reduced exacerbations, pneumonia hospitalizations seen versus ICS-LABAs in observational study May 23, 2023
Mucus Plugs in Airways of COPD Patients Linked to Higher Mortality In retrospective study, 54% mortality rate for those with mucus plugs in 3 or more lung segments May 22, 2023
Dupilumab Reduces COPD Exacerbations Lung function and symptoms also bettered with biologic in patients with type 2 Inflammation May 22, 2023
Cognitive Testing Flags COPD Patients Unable to Maintain Proper Inhaler Technique Lower MoCA scores associated with improper inhaler use despite face-to-face training Apr 28, 2023
Doctors Warn About Portable Oxygen Machines Sold Online OTC devices don't work as well as prescription devices -- if they work at all, study shows Apr 27, 2023
Low-Dose Morphine Not Helpful for COPD Patients With Chronic Dyspnea More research needed to distinguish physiological from behavioral effects of dyspnea Nov 22, 2022
Year in Review: COPD Early detection remains elusive, but treatments are reducing deaths Nov 01, 2022
Racial Disparities in Pulse Oximetry Persist; Sex Differences in COPD Treatment Studies from annual CHEST meeting spotlight disparities in care Oct 18, 2022
Less Invasive Emphysema Treatment Matches Lung Volume Reduction Surgery Bronchoscopic lung volume reduction with valve placement gets a boost from CELEB trial Sep 08, 2022
Are Antibiotics Needed for Moderate Acute Exacerbations of COPD? Maybe not for one subgroup of patients, says study from Germany Sep 06, 2022
Mucus Too Sticky? NAC Injections May Help Trial shows benefit with IV N-acetylcysteine in hospital setting Sep 05, 2022
Dual Bronchodilators No Help for Symptomatic Smokers With Preserved Lung Function RETHINC highlights why clinicians cannot keep giving these patients COPD meds, researcher says Sep 04, 2022
Global COPD Burden; Driving Restrictions After Fainting? Also in TTHealthWatch: best meds for insomnia and the effect of calorie labels in supermarkets Aug 06, 2022 podcast
Five Core Principles to Empower Our Patients Even through virtual care, promoting self-efficacy can lead to lasting behavior change May 20, 2022
